PubRank

D M Kaye

Author PubWeight™ 46.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 2008 2.93
2 Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996 1.84
3 Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995 1.80
4 Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2001 1.75
5 Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999 1.69
6 Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002 1.63
7 Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004 1.56
8 Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 2001 1.44
9 Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994 1.43
10 The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens 2000 1.42
11 Do we need cardiac arrest centres in Australia? Intern Med J 2012 1.39
12 Neural mechanisms in human obesity-related hypertension. J Hypertens 1999 1.30
13 Aging effects on human sympathetic neuronal function. Am J Physiol 1995 1.25
14 Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995 1.23
15 L-arginine transporters in cardiovascular disease: a novel therapeutic target. Pharmacol Ther 2007 0.98
16 Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 1995 0.95
17 Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J Am Coll Cardiol 2001 0.94
18 The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 2007 0.94
19 Regional sympathetic nervous activation after a large meal in humans. Clin Sci (Lond) 1995 0.94
20 Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am J Physiol 1998 0.93
21 Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling. Am J Physiol Heart Circ Physiol 2004 0.91
22 Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. J Auton Nerv Syst 1995 0.89
23 Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 2000 0.89
24 Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertens 1995 0.88
25 Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes. J Biol Chem 1997 0.87
26 Augmented endothelial-specific L-arginine transport prevents obesity-induced hypertension. Acta Physiol (Oxf) 2014 0.86
27 Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol Scand 1998 0.86
28 Arginase II inhibition prevents nitrate tolerance. Br J Pharmacol 2012 0.85
29 Regional 5-hydroxyindoleacetic acid production in humans. Life Sci 1995 0.85
30 Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 1997 0.83
31 The role of the NO pathway in the control of cardiac function. J Card Fail 1996 0.80
32 Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter. Br J Pharmacol 1999 0.80
33 Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. Clin Sci (Lond) 1999 0.79
34 Fallibility of plasma noradrenaline measurements in studying postprandial sympathetic nervous responses. J Auton Nerv Syst 1995 0.78
35 Identification of a novel, inhibitory action of amiodarone on vesicular monoamine transport. J Pharmacol Exp Ther 1999 0.78
36 Principles, current status and clinical implications of ischaemic heart disease assessment by cardiac magnetic resonance imaging. Intern Med J 2012 0.78
37 Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure. Eur J Heart Fail 2005 0.77
38 Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. Blood Press 1994 0.77
39 Endothelial cationic amino acid transporter-1 overexpression can prevent oxidative stress and increases in arterial pressure in response to superoxide dismutase inhibition in mice. Acta Physiol (Oxf) 2014 0.77
40 Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol 1996 0.75
41 Outcomes following de novo CNI-free immunosuppression after heart transplantation: a single-center experience. Am J Transplant 2008 0.75
42 Evidence that renal arginine transport is impaired in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2012 0.75
43 Effects of dietary marine oil supplementation on reactivity of human buttock subcutaneous arteries and forearm veins in vitro. Br J Pharmacol 1994 0.75
44 Reply to Bridges. Gene Ther 2009 0.75
45 Alterations in oxygen consumption and sympathetic nervous activity in heart failure: independent or associated mechanisms? Eur Heart J 2002 0.75
46 Catecholamine metabolites in internal jugular plasma: a window into the human brain. Adv Pharmacol 1998 0.75
47 Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc Res 1993 0.75
48 Cardiac resynchronisation therapy for heart failure. Intern Med J 2006 0.75
49 Restoration of nitric oxide function in human hyperlipidaemia, congestive heart failure and liver cirrhosis. Clin Exp Pharmacol Physiol 1998 0.75
50 Sympathetic nervous activity and the thermic effect of food in humans. Adv Pharmacol 1998 0.75
51 Central nervous system norepinephrine turnover in essential hypertension. Ann N Y Acad Sci 1995 0.75